WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Inc Stock Ownership - Who owns Day One Biopharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Day One Biopharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Samuel C. BlackmanHEAD OF RD2024-04-1810,000$16.02
$160.16kSell
Samuel C. BlackmanHEAD OF RD2024-03-2510,000$16.01
$160.06kSell
Samuel C. BlackmanHEAD OF RD2024-03-1130,000$15.24
$457.32kSell
Samuel C. BlackmanHEAD OF RD2024-02-2720,000$16.11
$322.16kSell
Adam DubowGENERAL COUNSEL2024-02-163,242$15.25
$49.43kSell
Samuel C. BlackmanHEAD OF RESEARCH AND DEVELOPME2024-02-162,258$15.25
$34.43kSell
Charles N. York IiCOO CFO AND SECRETARY2024-02-162,666$15.25
$40.65kSell
Jeremy BenderCHIEF EXECUTIVE OFFICER2024-02-167,615$15.25
$116.11kSell
Samuel C. BlackmanHead of Research and Developme2023-11-16709$11.69
$8.29kSell
Jeremy BenderChief Executive Officer2023-11-163,107$11.69
$36.32kSell

1 of 3

DAWN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DAWN insiders and whales buy or sell their stock.

DAWN Shareholders

What type of owners hold Day One Biopharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ai Day1 LLC14.80%12,929,322$170.80MInsider
Papanek Julie Grant12.82%11,199,207$147.94MInsider
Ai Day 1 LLC10.73%9,377,776$123.88MInsider
Ra Capital Management LP8.94%7,809,852$103.17MInstitution
Atlas Venture Life Science Advisors LLC8.71%7,608,394$100.51MInstitution
Canaan Xi LP7.97%6,964,301$92.00MInsider
Atlas Venture Fund Xi LP7.16%6,258,534$82.68MInsider
Takeda Pharmaceutical Co Ltd7.00%6,120,124$80.85MInsider
Blackrock Inc5.87%5,126,071$67.72MInstitution
Vanguard Group Inc5.46%4,769,746$63.01MInstitution

1 of 3

DAWN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DAWN54.70%45.30%Net BuyingNet Selling
KNSA48.25%9.83%Net SellingNet Selling
VRNA10.44%55.94%Net SellingNet Selling
LGND14.99%85.01%Net SellingNet Buying
SLNO20.62%79.38%Net BuyingNet Selling
View Top Biotech Stocks

Day One Biopharmaceuticals Stock Ownership FAQ

Who owns Day One Biopharmaceuticals?

Day One Biopharmaceuticals (NASDAQ: DAWN) is owned by 87.55% institutional shareholders, 72.51% Day One Biopharmaceuticals insiders, and 0.00% retail investors. Ai Day1 LLC is the largest individual Day One Biopharmaceuticals shareholder, owning 12.93M shares representing 14.80% of the company. Ai Day1 LLC's Day One Biopharmaceuticals shares are currently valued at $192.91M.

If you're new to stock investing, here's how to buy Day One Biopharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.